Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marjolein Droog

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Cancer Research|November 19, 2013
Hallmarks of aromatase inhibitor drug resistance revealed by epigenetic profiling in breast cancerMaurice P H M Jansen, Theo Knijnenburg, Esther A Reijm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2015
SRC3 Phosphorylation at Serine 543 Is a Positive Independent Prognostic Factor in ER-Positive Breast CancerWilbert Zwart, Koen D Flach, Bharath Rudraraju, et al.
Breast Cancer Research and Treatment|August 22, 2014
Phosphorylation of activating transcription factor-2 (ATF-2) within the activation domain is a key determinant of sensitivity to tamoxifen in breast cancerBharath Rudraraju, Marjolein Droog, Tarek M A Abdel-Fatah, et al.
Nature Genetics|August 22, 2025
Tamoxifen induces PI3K activation in uterine cancerKirsten Kübler, Agostina Nardone, Shankara Anand, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Cancer Research|November 19, 2013
Hallmarks of aromatase inhibitor drug resistance revealed by epigenetic profiling in breast cancerMaurice P H M Jansen, Theo Knijnenburg, Esther A Reijm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2015
SRC3 Phosphorylation at Serine 543 Is a Positive Independent Prognostic Factor in ER-Positive Breast CancerWilbert Zwart, Koen D Flach, Bharath Rudraraju, et al.
Breast Cancer Research and Treatment|August 22, 2014
Phosphorylation of activating transcription factor-2 (ATF-2) within the activation domain is a key determinant of sensitivity to tamoxifen in breast cancerBharath Rudraraju, Marjolein Droog, Tarek M A Abdel-Fatah, et al.
Nature Genetics|August 22, 2025
Tamoxifen induces PI3K activation in uterine cancerKirsten Kübler, Agostina Nardone, Shankara Anand, et al.
Pageof 2